Jill Jarecki

2.4k total citations
46 papers, 1.7k citations indexed

About

Jill Jarecki is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, Jill Jarecki has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Genetics, 20 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in Jill Jarecki's work include Neurogenetic and Muscular Disorders Research (41 papers), Congenital Anomalies and Fetal Surgery (12 papers) and RNA modifications and cancer (12 papers). Jill Jarecki is often cited by papers focused on Neurogenetic and Muscular Disorders Research (41 papers), Congenital Anomalies and Fetal Surgery (12 papers) and RNA modifications and cancer (12 papers). Jill Jarecki collaborates with scholars based in United States, United Kingdom and Switzerland. Jill Jarecki's co-authors include Mark A. Krasnow, Eric A. Johnson, Haig Keshishian, Arthur H.M. Burghes, Kenneth Hobby, Lisa Belter, Daniel D. Coovert, Sarah McGraw, Rosángel Cruz and Wei‐Shi Yeh and has published in prestigious journals such as Cell, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Jill Jarecki

44 papers receiving 1.6k citations

Peers

Jill Jarecki
Louise R. Simard Canada
Ivon Cuscó Spain
Raymond I. Haroun United States
Bruce H. Lipton United States
Cheryl Longman United Kingdom
Kinga K. Tomczak United States
Rosa Montes Spain
Takeo Kato Japan
Peter M. Kroisel Austria
Jo C. Bruusgaard Norway
Louise R. Simard Canada
Jill Jarecki
Citations per year, relative to Jill Jarecki Jill Jarecki (= 1×) peers Louise R. Simard

Countries citing papers authored by Jill Jarecki

Since Specialization
Citations

This map shows the geographic impact of Jill Jarecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Jarecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Jarecki more than expected).

Fields of papers citing papers by Jill Jarecki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Jarecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Jarecki. The network helps show where Jill Jarecki may publish in the future.

Co-authorship network of co-authors of Jill Jarecki

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Jarecki. A scholar is included among the top collaborators of Jill Jarecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Jarecki. Jill Jarecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curry, Mary Ann, Rosángel Cruz, Lisa Belter, Mary Schroth, & Jill Jarecki. (2024). Assessment of Barriers to Referral and Appointment Wait Times for the Evaluation of Spinal Muscular Atrophy (SMA): Findings from a Web-Based Physician Survey. Neurology and Therapy. 13(3). 583–598. 1 indexed citations
2.
Belter, Lisa, et al.. (2023). Telemedicine Use, Comfort, and Perceived Effectiveness in the Spinal Muscular Atrophy Community. Telemedicine Journal and e-Health. 30(2). 536–544. 4 indexed citations
3.
Belter, Lisa, et al.. (2023). Evaluating Perceived Fatigue within an Adult Spinal Muscular Atrophy Population. Neurology and Therapy. 12(6). 2161–2175. 3 indexed citations
4.
Glascock, Jacqueline, Basil T. Darras, Thomas O. Crawford, et al.. (2023). Identifying Biomarkers of Spinal Muscular Atrophy for Further Development. Journal of Neuromuscular Diseases. 10(5). 937–954. 16 indexed citations
5.
Curry, Mary Ann, et al.. (2023). Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community Insights. Neurology and Therapy. 12(5). 1631–1647. 1 indexed citations
6.
7.
8.
Cruz, Rosángel, et al.. (2020). The SMA Clinical Trial Readiness Program: creation and evaluation of a program to enhance SMA trial readiness in the United States. Orphanet Journal of Rare Diseases. 15(1). 118–118. 6 indexed citations
9.
Belter, Lisa, Rosángel Cruz, & Jill Jarecki. (2020). Health Utility Index Scores in treated and untreated patients with Spinal Muscular Atrophy: Findings from the 2019 Cure SMA Community Update Survey (4564). Neurology. 94(15_supplement). 1 indexed citations
10.
11.
Cruz, Rosángel, et al.. (2019). Evaluating Benefit-risk Decision-making in Spinal Muscular Atrophy: A First-ever Study to Assess Risk Tolerance in the SMA Patient Community. Clinical Therapeutics. 41(5). 943–960.e4. 19 indexed citations
12.
Belter, Lisa, Rosángel Cruz, & Jill Jarecki. (2019). Work Productivity Activity Impairment Results from the Cure SMA 2018 Community Update Survey (P1.9-070). Neurology. 92(15_supplement).
13.
Jones, Cynthia C., Suzanne F. Cook, Jill Jarecki, et al.. (2019). Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA Cohort. Journal of Neuromuscular Diseases. 7(1). 33–40. 15 indexed citations
14.
Glascock, Jacqueline, Jacinda B. Sampson, Amanda Haidet-Phillips, et al.. (2018). Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening. Journal of Neuromuscular Diseases. 5(2). 145–158. 143 indexed citations
15.
Glascock, Jacqueline, et al.. (2017). Cure SMA and our patient community celebrate the first approved drug for SMA. Gene Therapy. 24(9). 498–500. 11 indexed citations
16.
Qian, Ying, Sarah McGraw, Jeff Henne, et al.. (2015). Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study. BMC Neurology. 15(1). 217–217. 98 indexed citations
17.
Cherry, Jonathan J., Dione Kobayashi, Francesco Danilo Tiziano, et al.. (2014). Assays for the Identification and Prioritization of Drug Candidates for Spinal Muscular Atrophy. Assay and Drug Development Technologies. 12(6). 315–341. 23 indexed citations
18.
Butchbach, Matthew E.R., J. J. Singh, Margrét Þorsteinsdóttir, et al.. (2009). Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy. Human Molecular Genetics. 19(3). 454–467. 94 indexed citations
19.
Jarecki, Jill, Daniel D. Coovert, Michael Whitney, et al.. (2005). Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. Human Molecular Genetics. 14(14). 2003–2018. 119 indexed citations
20.
Jarecki, Jill, Eric A. Johnson, & Mark A. Krasnow. (1999). Oxygen Regulation of Airway Branching in Drosophila Is Mediated by Branchless FGF. Cell. 99(2). 211–220. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louise R. Simard Breakdown of academic impact, for papers by Ivon Cuscó Breakdown of academic impact, for papers by Raymond I. Haroun Breakdown of academic impact, for papers by Bruce H. Lipton Breakdown of academic impact, for papers by Cheryl Longman Breakdown of academic impact, for papers by Kinga K. Tomczak Breakdown of academic impact, for papers by Rosa Montes Breakdown of academic impact, for papers by Takeo Kato Breakdown of academic impact, for papers by Peter M. Kroisel Breakdown of academic impact, for papers by Jo C. Bruusgaard
Rankless by CCL
2026